Sensitive nanowire disease detectors made by Yale scientistsOctober 13, 2008New Haven, Conn. - Yale scientists have created nanowire sensors coupled with simple microprocessor electronics that are both sensitive and specific enough to be used for point-of-care (POC) disease detection, according to a report in Nano Letters. The sensors use activation of immune cells by highly specific antigens - signatures of bacteria, viruses or cancer cells - as the detector. When T cells are activated, they produce acid, and generate a tiny current in the nanowire electronics, signaling the presence of a specific antigen. The system can detect as few as 200 activated cells. In earlier studies, these researchers demonstrated that the nanowires could detect generalized activation of this small number of T cells. The new report expands that work and shows the nanowires can identify activation from a single specific antigen even when there is substantial background "noise" from a general immune stimulation of other cells.
Describing the sensitivity of the system, senior author Tarek Fahmy, Yale assistant professor of biomedical engineering, said:. "Imagine I am the detector in a room where thousands of unrelated people are talking - and I whisper, 'Who knows me?' I am so sensitive that I can hear even a few people saying, 'I do' above the crowd noise. In the past, we could detect everyone talking - now we can hear the few above the many." According to the authors, this level of sensitivity and specificity is unprecedented in a system that uses no dyes or radioactivity. Beyond its sensitivity, they say, the beauty of this detection system is in its speed - producing results in seconds - and its compatibility with existing CMOS electronics. "We simply took direction from Mother Nature and used the exquisitely sensitive and flexible detection of the immune system as the detector, and a basic physiological response of immune cells as the reporter," said postdoctoral fellow and lead author, Eric Stern. "We coupled that with existing CMOS electronics to make it easily usable." The authors see a huge potential for the system in POC diagnostic centers in the US and in underdeveloped countries where healthcare facilities and clinics are lacking. He says it could be as simple as an iPod-like device with changeable cards to detect or diagnose disease. Importantly, Stern notes that the system produces no false positives - a necessity for POC testing. The authors suggest that in a clinic, assays could immediately determine which strain of flu a patient has, whether or not there is an HIV infection, or what strain of tuberculosis or coli bacteria is present. Currently, there are no electronic POC diagnostic devices available for disease detection. "Instruments this sensitive could also play a role in detection of residual disease after antiviral treatments or chemotherapy," said Fahmy. "They will help with one of the greatest challenges we face in treatment of disease - knowing if we got rid of all of it." Yale University | |||||||||||||||||||||
|
Related Disease Detection Current Events and Disease Detection News Articles Researchers write protein nanoarrays using a fountain pen and electric fields Nanotechnology offers unique opportunities to advance the life sciences by facilitating the delivery, manipulation and observation of biological materials with unprecedented resolution. New Electrostatic-based DNA Microarray Technique Could Revolutionize Medical Diagnostics The dream of personalized medicine - in which diagnostics, risk predictions and treatment decisions are based on a patient's genetic profile - may be on the verge of being expanded beyond the wealthiest of nations with state-of-the-art clinics. Scientists: New technique identifies molecular 'biomarkers' for disease University of Florida chemists are the first to use a new tool to identify the molecular signatures of serious diseases -- without any previous knowledge of what these microscopic signatures or "biomarkers" should look like. Proteomic profiling shown more accurate than traditional biomarkers in identifying liver cancer As the incidence of liver cancer continues to grow-- fueled in large part, by rising rates of hepatitis C infections - so too does the need for tests to help diagnose the disease at an earlier stage. University of Toronto scientists map entire yeast genome University of Toronto scientists have devised a tool to help understand and predict the state of a cell by successfully mapping all 70,000 nucleosomes in yeast. Nucleosomes wrap DNA before it is transformed into proteins and are critical indicators and regulators of a cell's state. Bacteria ferry nanoparticles into cells for early diagnosis, treatment Researchers at Purdue University have shown that common bacteria can deliver a valuable cargo of "smart nanoparticles" into a cell to precisely position sensors, drugs or DNA for the early diagnosis and treatment of various diseases. New MRI technique shows emphysema in asymptomatic smokers A new imaging method has revealed early signs of emphysema in smokers with no external symptoms of the disease, according to a study published in the June issue of Radiology. Breakthrough: UNC scientists have created world's tiniest uniform, precisely shaped organic particles University of North Carolina at Chapel Hill chemists have developed what they believe is a breakthrough method of creating the world's tiniest manufactured particles for delivering drugs and other organic materials into the human body. Scientists Develop Technology To Detect Cancer Researchers at the University of Liverpool have developed a breakthrough technology that identifies molecular markers in early lung cancer. HPV testing could be future strategy for primary screening for cervical cancer (pp 1866, 1871) Embargoed 0001 h (London time) 5 December 2003. Authors of a UK study in this week's issue of THE LANCET propose a new approach for cervical cancer screening. Testing for the human papilloma virus (HPV)-the main cause of cervical cancer-could be the primary screening tool, with cytology reserved for women who test positive for HPV. HPV testing (by genetic analysis) of cervical smears is known to be more sensitive than conventional cytology for detecting pre-malignant cervical cells called high-grade cervical intraepithelial neoplasia (CIN2/CIN3); however HPV testing is less specific than cytology (ie. it produces more 'false-positive' results). HPV testing as a primary screening approach is More Disease Detection Current Events and Disease Detection News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||